Swift Biosciences has launched two new products over the last year, enabling the 4-year-old life sciences firm to add to its staff.
The Ann Arbor-based company is developing molecular biology reagents for research and diagnostic applications that provide new ways to examine disease-related genes. This genomic sequencing technology helps researchers analyze samples faster, at a higher volume, and at a lower price per sample.
Among its two new product lines are its Accel-NGS Amplicon panels, which help molecular biologists detect and screen clinically relevant mutations. Swift Biosciences also a new next generation sequencing sample preparation kit called Accel-NGS that is designed to accelerate sample preparation.
"It shows great differentiation over our competitors to allow people to glean more data from the sample," says Matthew Hymes, marketing manager for
Swift Biosciences.
Swift Biosciences has raised $13.15 million in venture capital, including a $7 million Series B it closed on earlier this year. The company has hired five people over the last year, expanding its staff to 20 people. Those new hires include professionals in marketing, product development, bio-informatics. It is also looking to hire a commercial coordinator right now.
Swift Biosciences is also looking to launch three new products in 2015. Products that would expand on its Accel-NGS Amplicon panels, among other applications.
"We have more products in the pipeline to launch," Hymes says.
Source: Matthew Hymes, marketing manager for Swift Biosciences
Writer: Jon Zemke
Read more about Metro Detroit's growing entrepreneurial ecosystem at SEMichiganStartup.com.
Enjoy this story?
Sign up for free solutions-based reporting in your inbox each week.